Investors, governments and consumers around the world are continuing to challenge corporations to aggressively reduce their environmental footprints. To date, 83 percent of Fortune 500 companies have ...

Nucleome Therapeutics ('Nucleome' or 'the Company'), a company tackling the molecular causes of inflammatory diseases through a ...

The Animal Genetics Market is projected to experience a CAGR of 6-7% between 2023 and 2028. The key factors driving the market include increasing demand for animal protein, growing interest in ...

A University of Tennessee Health Science Center team has received $2.05 million from the National Cancer Institute for an advanced genetics project that could help develop targeted therapies and ...

Relative Genetics has announced the availability of enhanced mitochondrial DNA testing services that improve the accuracy and reach of maternal lineage information. Mitochondrial DNA is passed ...